ArticleJournal of cancer research and clinical oncology2019

Fibroblast growth factor receptor 4 (FGFR4) as detected by immunohistochemistry is associated with postoperative residual disease in ovarian cancer.

Sabine Heublein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.